Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

SEN. Erwin Tulfo on Monday lauded President Marcos’ veto of P92.5 billion worth of projects under the unprogrammed ...

Ryan Stokes’ audacious $14bn move on BlueScope starts the new year with a bang as his SGH conglomerate – previously named ...

Detailed price information for Nord Precious Metals Mining Inc (NTH-X) from The Globe and Mail including charting and trades.

Documents, denials, and the weight of power continue to hang heavily over the House of Representatives as allegations against Speaker Richard Nagbe Koon deepen into one of the most consequential ...

By bridging the gap between theoretical logic and practical application, the syllabus fosters the technical proficiency and ...

Trio Petroleum Corp (NYSE American: TPET) ("Trio" or the "Company"), an oil and gas company, today is pleased to announce that its wholly owned Canadian subsidiary, Trio Petroleum Canada, Corp. (the ...

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is ...

GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.